Literature DB >> 2867185

The binding of flurbiprofen to plasma proteins.

L Aarons, A Z Khan, D M Grennan, M Alam-Siddiqi.   

Abstract

The binding of flurbiprofen to human serum albumin and normal plasma was measured using ultracentrifugation. Flurbiprofen was bound in excess of 99% in all cases. Over the concentration range normally associated with therapy the data could be adequately described by a one-site binding model. The association constant decreased with increasing protein concentration, being 3.04 X 10(6) M-1 at an albumin concentration, of 2 g/100 ml and 1.19 X 10(6) M-1 at a concentration of 4 g/100 ml. Flurbiprofen binding showed no dependence on pH over the range 7.0 to 8.0.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2867185     DOI: 10.1111/j.2042-7158.1985.tb05101.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  3 in total

1.  The effects of liver and renal disease on stereoselective serum binding of flurbiprofen.

Authors:  R Blouin; I Chaudhary; K Nishihara; S Cox
Journal:  Br J Clin Pharmacol       Date:  1993-01       Impact factor: 4.335

2.  Plasma and synovial fluid kinetics of flurbiprofen in rheumatoid arthritis.

Authors:  L Aarons; R Salisbury; M Alam-Siddiqi; L Taylor; D M Grennan
Journal:  Br J Clin Pharmacol       Date:  1986-02       Impact factor: 4.335

3.  Muscle Tissue as a Surrogate for In Vitro Drug Release Testing of Parenteral Depot Microspheres.

Authors:  Jan Kozak; Miloslava Rabiskova; Alf Lamprecht
Journal:  AAPS PharmSciTech       Date:  2021-03-29       Impact factor: 3.246

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.